Bone-targeted agents in multiple myeloma

Por Nishida, Hiroko
Publicado no Hematol Rep (2018)

Monoclonal Antibody Therapies in Multiple Myeloma: A Challenge to Develop Novel Targets

Por Nishida, Hiroko, Yamada, Taketo
Publicado no J Oncol (2019)

Primary isolated bone marrow diffuse large B cell lymphoma with long-term complete remission

Por Nishida, Hiroko, Suzuki, Hiroshi, Hori, Masao, Obara, Katsuyuki
Publicado no Leuk Res Rep (2018)

CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma

Por Nishida, Hiroko, Hayashi, Mutsumi, Morimoto, Chikao, Sakamoto, Michiie, Yamada, Taketo
Publicado no Blood Cancer J (2018)

The Assembly and Maintenance of Heterochromatin Initiated by Transgene Repeats Are Independent of the RNA Interference Pathway in Mammalian Cells

Por Wang, Fangwei, Koyama, Naoki, Nishida, Hiroko, Haraguchi, Tokuko, Reith, Walter, Tsukamoto, Toshiro
Publicado em 2006

A humanized anti-CD26 monoclonal antibody inhibits cell growth of malignant mesothelioma via retarded G2/M cell cycle transition

Por Hayashi, Mutsumi, Madokoro, Hiroko, Yamada, Koji, Nishida, Hiroko, Morimoto, Chikao, Sakamoto, Michiie, Yamada, Taketo
Publicado no Cancer Cell Int (2016)

Novel Antibody-Drug Conjugate with Anti-CD26 Humanized Monoclonal Antibody and Transcription Factor IIH (TFIIH) Inhibitor, Triptolide, Inhibits Tumor Growth via Impairing mRNA Synt...

Por Hayashi, Mutsumi, Madokoro, Hiroko, Yamada, Koji, Nishida, Hiroko, Morimoto, Chikao, Sakamoto, Michiie, Yanagawa, Hiroshi, Yamada, Taketo
Publicado no Cancers (Basel) (2019)

Nuclear Localization of CD26 Induced by a Humanized Monoclonal Antibody Inhibits Tumor Cell Growth by Modulating of POLR2A Transcription

Por Yamada, Kohji, Hayashi, Mutsumi, Madokoro, Hiroko, Nishida, Hiroko, Du, Wenlin, Ohnuma, Kei, Sakamoto, Michiie, Morimoto, Chikao, Yamada, Taketo
Publicado em 2013